CN101816745B - Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof - Google Patents
Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof Download PDFInfo
- Publication number
- CN101816745B CN101816745B CN2009103125597A CN200910312559A CN101816745B CN 101816745 B CN101816745 B CN 101816745B CN 2009103125597 A CN2009103125597 A CN 2009103125597A CN 200910312559 A CN200910312559 A CN 200910312559A CN 101816745 B CN101816745 B CN 101816745B
- Authority
- CN
- China
- Prior art keywords
- radix
- fructus
- chinese medicine
- root
- chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a Chinese medicine composite applicable to treating ascitesduetocirrhosis, comprising the following effective components by weight percent: 7.8%-9.8% of radix codonopsis pilosulae, 7.8%-9.8% of white paeony root, 7.8%-9.8% of Chinese magnoliavine fruit, 7.8%-9.8% of Chinese wolfberry, 4.2-6.6% of rehmanniae vaporata, 4.2-6.6% of star anise, 4.2-6.6% of panax pseudoginseng, 4.2-6.6% of radix angelicae pubescentis, 4.2-6.6% of Indian buead, 2.6%-4.6% of tangerine peel, 2.6%-4.6% of hawthorn, 2.6%-4.6% of rhizoma atractylodis macrocephaiae, 2.6%-4.6% of Chinese eaglewood, 2.6%-4.6% of anemarrhenae, 0.8%-2.8% of root of straight ladybell, 0.8%-2.8% of himalayan teasel root, 0.8%-2.8% of szechuan lovage rhizome, 0.8%-2.8% of twotooth achyranthes root, 0.8%-2.8% of root of largeleaf gentian, 0.8%-2.8% of date kernels, 0.8%-2.8% of otophora unilocularis, 0.8%-2.8% of Chinese clematis, 0.8%-2.8% of liquorice, 0.8%-2.8% of nodakenin, 0.8%-2.8% of cinnamon and the like, the sum of the content of the components is 100%. The well-weighed components are evenly stirred and grinded into fine powder to obtain the compound in the invention. The Chinese medicine composite in the invention has high effect, no toxic or side effect, stable curative effect and convenient use, and the disease is not easy to relapse.
Description
Technical field
The invention belongs to the Chinese drug preparation technique field, relate to the Chinese medicine composition that is applicable to the treatment cirrhotic ascites, the invention still further relates to the preparation method of this Chinese medicine composition.
Background technology
Liver cirrhosis is a kind of common chronic hepatopathy, can cause by one or more reasons, be carrying out property, diffusivity, fibrous lesions, can cause hepatocyte diffusivity degeneration necrosis, thereby proliferation of fibrous tissue and the regeneration of hepatocyte nodositas appear, and then cause lobules of liver destroyed in conjunction with blood circulation, and make liver distortion, hardening, cause taking place the liver cirrhosis complication, cause the portal hypertension hepatic insufficiency, upper gastrointestinal hemorrhage, liver property brain decreases complication, and then causes death.
The liver cirrhosis cause of disease is many, but mainly contains viral hepatitis, the chronic alcoholism cirrhotic ascites, and malnutrition and toxic hepatitis, cirrhotic ascites and hepatic necrosis, and the main pathogenesis of liver cirrhosis is the hepatic fibrosis of carrying out property.Hepatopathy is not a kind of local patholoic change, but systemic disease is poly-in partial reaction and virus knot, the essence that imbalance of YIN and YANG should disease, so treatment this when sick, must nurse one's health comprehensively, the emphasis medication finally reaches the equilibrium between yin and yang under the naturalness, changes tangible in virtually, and hepatic fibrosis, liver cirrhosis are processes slowly, if we early find, early treatment, liver cirrhosis is treatable, and hepatocarcinoma also can be cured.
Existing western medicine cirrhotic ascites because toxicity is big, so side effect is big, and can't reach the radical cure effect; And adopt methods such as operation, radiotherapy, chemotherapy to treat, and also having big toxic and side effects, the patient can suffer huge misery, and effect is not satisfactory.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition that is applicable to the treatment cirrhotic ascites, instant effect, cure rate height, have no side effect, curative effect is firm, be difficult for recurrence, and is and easy to use.
Another object of the present invention provides the preparation method of above-mentioned composition.
The technical solution adopted in the present invention is, a kind of Chinese medicine composition that is applicable to the treatment cirrhotic ascites is made up of the active component of following raw material by mass percentage:
Radix Codonopsis 7.8%-9.8%, Radix Paeoniae Alba 7.8%-9.8%, Fructus Schisandrae Chinensis 7.8%-9.8%, Fructus Lycii 7.8%-9.8%, Radix Rehmanniae Preparata 4.2%-6.6%, Fructus Anisi Stellati 4.2%-6.6%, Radix Notoginseng 4.2%-6.6%, Radix Angelicae Pubescentis 4.2%-6.6%, Poria 4.2%-6.6%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, MUZHUA 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%.
Another technical scheme of the present invention is, the preparation method of above-mentioned Chinese medicine composition is carried out according to following steps:
Step 1 takes by weighing Radix Codonopsis 7.9%-9.9% by mass percentage, Radix Paeoniae Alba 7.9%-9.9%, Fructus Schisandrae Chinensis 7.9%-9.9%, Fructus Lycii 7.9%-9.9%, Radix Rehmanniae Preparata 4.4%-6.4%, Fructus Anisi Stellati 4.4%-6.4%, Radix Notoginseng 4.4%-6.4%, Radix Angelicae Pubescentis 4.4%-6.4%, Poria 4.4%-6.4%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, MUZHUA 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%;
Step 2, with two-part all medicines that step 1 prepares, even respectively mediation and grind into fine powder are promptly.
Chinese medicine composition of the present invention can invigorating QI and blood, Yin Yang balancing, promoting blood circulation, nourishing yin and promoting granulation improves immunocompetence, again can regulating QI to relieve pain, hard masses softening and resolving, blood circulation promoting and blood stasis dispelling, dispel and poison the stasis of blood, detumescence is relieved oedema or abdominal distension through diuresis or purgation, and is used for hepatitis B, fatty liver toxicity cirrhotic ascites, alcoholic cirrhosis ascites, hepatic cyst, and hepatic disease such as other hepatitis, hepatoma.
The specific embodiment
The present invention is described in detail below in conjunction with specific embodiment.
Chinese medicine composition of the present invention is made up of the active component of following raw material: Radix Codonopsis 7.8%-9.8%, Radix Paeoniae Alba 7.8%-9.8% by mass percentage, Fructus Schisandrae Chinensis 7.8%-9.8%, Fructus Lycii 7.8%-9.8%, Radix Rehmanniae Preparata 4.2%-6.6%, Fructus Anisi Stellati 4.2%-6.6%, Radix Notoginseng 4.2%-6.6%, Radix Angelicae Pubescentis 4.2%-6.6%, Poria 4.2%-6.6%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, MUZHUA 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%.
One, function and the function of each raw material in this medicine cures mainly:
Radix Codonopsis: belong to monarch drug in this prescription, main effect has invigorating the spleen and replenishing QI, the spleen invigorating lung benefiting.Nature and flavor are flat, and are sweet, little acid.Return spleen, lung two warps.Its chemical constituent has the Radix Codonopsis saponin, polysaccharide, phenols, sterol, volatile oil, Radix Scutellariae element etc.
The Radix Paeoniae Alba: belong to monarch drug in this prescription, main effect has nourishing blood to suppress the hyperactive liver, slow middle pain relieving, and yin fluid astringing is received antiperspirant; Be used for breast abdomen hypochondriac pain, broken hard eliminate indigestion ends irritability pain.The nature and flavor hardship, flat.Return liver, spleen channel.Its chemical analysis has peoniflorin, careless medicine flower glycoside, fatty oil, tannic acid, polysaccharide etc.
Fructus Schisandrae Chinensis: belong to monarch drug in this prescription, main effect has convergence astringent or styptic treatment for spontaneous sweating, supplementing QI for promoting the production of body fluid, and the five internal organs are protected in kidney calming, and alcoholic intoxication protects the liver, and the regeneration liver organization improves immunocompetence.The nature and flavor temperature, acid, sweet.Return lung, the heart, kidney channel.Its chemical analysis has Fructus Schisandrae Chinensis Li Su, schisandrol, Fructus Schisandrae Chinensis fat.
Fructus Lycii: belong to monarch drug in this prescription, main effect is tonified Qi of the kidney nourishing the liver to improve visual acuity, blood-enriching tranquillizing, promoting the production of body fluid to quench thirst; Be used for hepatic and renal YIN deficiency, hard smart bone, fatigue taking away.Nature and flavor are sweet, and are flat.Go into liver, stomach two warps.Its chemical analysis has Radix Dauci Sativae Lee, sulphuric acid element, riboflavin, ascorbic acid, cupreol etc.
Radix Rehmanniae Preparata: belong to monarch drug in this prescription, the main effect YIN nourishing of enriching blood, vital essence replenishing and marrow benifiting is changed disease.Nature and flavor are sweet, flat.Go into blood system, return liver, kidney channel.The useful Adiantum monochlamys Eaton. glycoside of its chemical analysis, rehmannioside, iridoid constituents.
Fructus Anisi Stellati: belong to monarch drug in this prescription, main effect has warming YANG to expel cold, regulating QI to relieve pain.The nature and flavor suffering, temperature.Return liver, kidney, stomach warp.Its chemical constituent has Oleum Anisi Stellati, fenchene and dehydration pentose etc.
Radix Notoginseng: belong to monarch drug in this prescription, main effect has dissipating blood stasis hemostasis, subduing swelling and relieving pain; Be used for antiinflammatory, antitumor, defying age, blood fat reducing, hepatoprotective.The nature and flavor temperature, sweet.Return liver, stomach warp.Its chemical analysis has the ginsenoside, the flavone soap.
Radix Angelicae Pubescentis: in this prescription, belong to monarch drug, the main effect temperature of dispeling the wind, it is lame to end numbness, detoxifcation; To the formation of thrombosis, platelet aggregation has specially good effect.The nature and flavor suffering, hardship, temperature.Return kidney, urinary bladder channel.Its chemical analysis has columbianetin and acetas thereof, Angelica pubescens alcohol etc.
Poria: belong to monarch drug in this prescription, main effect has promoting diuresis to eliminate damp pathogen, spleen invigorating mind calming, heat radiation evacuation of pus.Nature and flavor are sweet, and are light, flat.GUIXIN, spleen, kidney channel.Its chemical analysis has pachymic acid, lecithin, choline, the acid of group base, ergosterol.
Pericarpium Citri Reticulatae: belong to ministerial drug in this prescription, main effect has regulating qi-flowing for strengthening spleen, and wet dissipation reduces phlegm.The nature and flavor suffering, hardship, temperature.Return spleen, lung meridian.Its chemical analysis has hesperetin, volatile oil, Hesperidin, chromocor compound.
Fructus Crataegi: belong to ministerial drug in this prescription, main effect has promoting digestion and invigorating the stomach, the circulation of qi promoting dissipating blood stasis, and eliminate indigestion helps digestion, strengthening the spleen and stomach.Nature and flavor are sweet, acid, tepor.Return spleen, stomach, Liver Channel.Its chemical analysis has flavone compound, and soap is sweet, fatty acid, inorganic salt, multiannensional-sine.
The Rhizoma Atractylodis Macrocephalae: be messenger drug in this prescription, main effect has invigorating the spleen and benefiting QI, the dampness diuretic; Be used for the treatment of insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, and throbs with fear in the phlegm retention chamber, edema, spontaneous perspiration, liver cirrhosis clothes water, and the auxiliary treatment of hepatoprotective; Especially kidney and other internal organs there is defying age, antioxidation, anticoagulation, effects such as anti-tumor.The nature and flavor hardship, sweet, temperature.Return spleen, stomach warp.Its chemical analysis has volatile oil, and main constituent is an atractylone in the oil, atractylodes lactone, 3-β acetoxyl group atractylone, 3-β hydroxyl atractylone etc.
Lignum Aquilariae Resinatum: belong to ministerial drug in this prescription, main effect has promoting the circulation of QI to relieve pain, warming middle-JIAO to arrest vomiting, helping inspiration to relieve asthma.The nature and flavor suffering, hardship, tepor.Return spleen, kidney, stomach warp.Its chemical analysis has resin, baimuxinic acid, Shen Xiang spiral alcohol.
The Rhizoma Anemarrhenae: belong to ministerial drug in this prescription, main effect has heat-clearing and toxic substances removing, and pathogenic fire purging is promoted the production of body fluid and moisturized.The nature and flavor hardship, sweet cold.Return kidney, stomach, lung three warps.Its chemical analysis has the sweet unit of Fructus Piperis Longi soap.
Radix Adenophorae (Radix Glehniae): belong to messenger drug in this prescription, main effect has nourishing YIN and clearing away lung-heat, reinforcing stomach reg fluid.The nature and flavor hardship is slightly cold, and is nontoxic.Attach to the lung and stomach meridians.Its chemical analysis has Radix Adenophorae (Radix Glehniae) Saponin.
Radix Dipsaci: belong to adjuvant drug in this prescription, main effect has invigorating the liver and kidney, bone and muscle strengthening.Nature and flavor are sweet, hardship, suffering.Return liver, kidney channel.Its chemical analysis has triterpene saponin, erythricine, carotene, volatilization wet goods.
Rhizoma Chuanxiong: belong to adjuvant drug in we, main effect has blood-activating and qi-promoting, wind-expelling pain-stopping.The nature and flavor suffering, temperature.Return liver, gallbladder, pericardium channel.Its chemical analysis has the Rhizoma Chuanxiong element, what acid Wei, lactone element, vitamin A, folic acid, sterol, fatty oil.
Radix Achyranthis Bidentatae: in this prescription, belong to adjuvant drug, the main favourable Liver and kidney of effect, bone and muscle strengthening, promoting blood circulation to restore menstrual flow, conducting blood to flow downwards, inducing diuresis for treating stranguria syndrome.The nature and flavor hardship, acid, flat.Return liver, kidney channel.Its chemical analysis has triterpene saponin, polysaccharide, alkaloid, coumarin.
Radix Gentianae Macrophyllae: belong to adjuvant drug in this prescription, main effect has wind-damp dispelling, stopping numbness pain, reducing the asthenic fever, clearing away damp-heat, jaundice eliminating subcutaneous ulcer, following water.The nature and flavor suffering, hardship is slightly cold.Return stomach, liver, gallbladder meridian.Its chemical constituent has alkaloid, and the Radix Gentianae hardship is sweet, sweroside etc.
Semen Ziziphi Spinosae: belong to messenger drug in this prescription, main effect has tranquilizing by nourishing the heart, arresting sweating.Nature and flavor are flat, and are sweet, acid.GUIXIN, Liver Channel.Its chemical analysis has Semen Ziziphi Spinosae Saponin, flavone, fatty oil, betula camphor.
Fructus Chaenomelis: belong to messenger drug in this prescription, main effect has relaxing muscles and tendons and activating QI and blood in the collateral, and the removing dampness of being good for the stomach is used for viral hepatitis.Nature and flavor acid, temperature.Return liver, spleen channel.Its chemical analysis has papaya powder, and soap is sweet, vitamin C, flavone compound.
Radix Clematidis: belong to messenger drug in this prescription, main effect has lowering the adverse-rising QI to resolve phlegm, wind-dispelling heat-dissipating, the heat of reducing phlegm, the ailment said due to cold or exposure of loosing; With the disease compatibility drug; Be used for the treatment of the bacterium profit, enteritis.The nature and flavor suffering is salty, and temperature is poisonous.Return lung meridian.Its chemical analysis has main peucedanin, the decuroside compounds.
Radix Glycyrrhizae: belong to messenger drug in this prescription, main effect has QI invigorating invigorating middle warmer, heat-clearing and toxic substances removing, expelling phlegm for arresting cough, relieving spasm to stop pain, coordinating the actions of various ingredients in a prescription; Be used for hepatitis, liver cirrhosis clothes water, liver tumor etc.Nature and flavor are sweet, and are flat.Return 12 warps.Its chemical constituent mainly contains triterpenoid saponin, glycyrrhizin, glycyrrhizic acid and flavone compound etc.
Radix Peucedani: belong to messenger drug in this prescription, main effect has lowering the adverse-rising QI to resolve phlegm, wind-dispelling heat-dissipating; Be used for clearing away lung-heat, enteritis, digestive tract disease.The nature and flavor hardship, suffering is slightly cold.Return lung meridian.Its chemical analysis has dulcin, coumarin, decursinol.
Cortex Cinnamomi: belong to messenger drug in this prescription, main effect is enriched blood supporing yang, let the fire back to its origin, and dispersing cold for relieving pain, promoting blood circulation to restore menstrual flow, warming the meridian and promoting blood circulation has calmness, and blood pressure lowering is good for the stomach, effects such as easy intestinal.The nature and flavor suffering, sweet, heat.Return kidney,spleen,liver, heart channel.Its chemical analysis has volatile oil, cinnamic aldehyde, syringic acid.
Above prescription can benefiting vital QI and blood, active promoting blood circulation, reinforcing spleen and kidney, invigorating the spleen and regulating the stomach, eliminating dampness and promoting diuresis, nourishing the kidney and liver, reducing swelling and alleviating pain, the blood stasis dispelling poison of dispelling, conditioning the five internal organs, profit six internal organs.
3. function cures mainly:
Hepatitis, cirrhotic ascites, alcoholic liver and cirrhotic ascites, fatty liver, hepatic cyst, hepatocarcinoma, intestinal tract diseases such as intestinal cancer.
Two, preparation method and usage and dosage
The pill preparation method of Chinese medicine composition of the present invention, carry out according to following steps:
Step 1 takes by weighing Radix Codonopsis 7.8%-9.8% by mass percentage, Radix Paeoniae Alba 7.8%-9.8%, Fructus Schisandrae Chinensis 7.8%-9.8%, Fructus Lycii 7.8%-9.8%, Radix Rehmanniae Preparata 4.2%-6.6%, Fructus Anisi Stellati 4.2%-6.6%, Radix Notoginseng 4.2%-6.6%, Radix Angelicae Pubescentis 4.2%-6.6%, Poria 4.2%-6.6%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, MUZHUA 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%.
Step 2, all medicines that step 1 is taken by weighing evenly are in harmonious proportion, and are ground into the powder that particle diameter is 20-50pm, remove impurity, and making 9 grams with Mel is the pill of a ball.
The usage of the pill of Chinese medicine composition of the present invention and consumption,
The patient divides and to take night and morning, and takes one piece of the pill that this Chinese medicine composition makes at every turn.
The oral liquor of Chinese medicine composition of the present invention, carry out according to following steps:
Step 1, method for making such as pill preparation method step 1.
Step 2, all medicines that step 1 is taken by weighing evenly are in harmonious proportion, add behind the water fried, with the oral liquid of one of medicinal liquid simmer down to 20ml.
The usage of the oral liquid of Chinese medicine composition of the present invention and consumption,
The patient divides and to take night and morning, and takes one of the oral liquid that this Chinese medicine composition makes at every turn.
The sublimed preparation preparation method of Chinese medicine composition of the present invention, carry out according to following steps:
Step 1, method for making such as pill preparation method step 1.
Step 2, all medicines that step 1 is taken by weighing evenly are in harmonious proportion, and grind into fine powder is made the 0.1 red ball that restrains after the purification.
The usage of the sublimed preparation of Chinese medicine composition of the present invention and consumption,
The patient divides and to take night and morning, and takes 60 of the sublimed preparation that this Chinese medicine composition makes at every turn.
The decoction preparation method of Chinese medicine composition of the present invention, carry out according to following steps:
Step 1, method for making such as pill preparation method step 1.
Step 2, all medicines that step 1 is taken by weighing evenly are in harmonious proportion, and add behind the water promptly fried.
The usage of the decoction of Chinese medicine composition of the present invention and consumption,
Patient's branch takes night and morning, and takes decoction one pair that this Chinese medicine composition is made at every turn.
Three, clinical experiment data
Select 245 hepatitis, the patient of cirrhotic ascites or ethanol cirrhotic ascites is as treatment target, and wherein 195 people are experimental group, and 50 people are matched group; Patient to experimental group uses Chinese medicine composition of the present invention to treat, and the patient of matched group uses liver-protecting tablet to treat.To the clinical treatment observation of Chinese medicine composition of the present invention, to carry out the tracing observation in 10 years continuously, and done data analysis on the books, the healing situation sees Table 1.
Table 1. adopts Chinese medicine composition of the present invention and the therapeutic effect table that adopts liver-protecting tablet
| Group | Obvious effective rate | Effective percentage | Inefficiency | Total effective rate |
| The treatment group | 68.2％ | 28.6％ | 3.2％ | 96.8％ |
| Matched group | 33.3％ | 20％ | 46.7％ | 53.3％ |
As can be seen, Chinese medicine composition of the present invention is remarkable to cirrhotic ascites and ethanol cirrhotic ascites effect.
Four, toxicity report
Chinese medicine composition of the present invention belongs to oral drugs, the toxic medicine of every flavor is all in the safe dose scope, all medicine compatibilities, interact, and Radix Glycyrrhizae conditioning is arranged, the property of medicine is emitted by becoming slow release strongly, absorb the row of discharging all in safety, and be furnished with hepatoprotective, protect kidney, the medicine of stomach function regulating, endo-medicine is slowly played a role in vivo.Can occur the untoward reaction of giddy, vomiting, constipation after having a few peoples to obey, drug eruption can appear in only a few people, patient's anti symptom treatment of untoward reaction occurs or cuts out this Chinese medicine composition above-mentioned, and above untoward reaction just can be eliminated.
Five, clinical example
Liu Hongyou, the man, 47 years old, Shaanxi Province's Zichang County watt town cadre of town caused alcoholism because of being addicted to drink, be diagnosed as alcoholic liver in February, 2002, after develop into alcoholic cirrhosis ascites, multi-treatment is invalid, takes Chinese medicine composition of the present invention after three months, returns to one's perfect health.
Bai Lili, the woman, 46 years old, Zichang County cadre of industrial and commercial bureau in Shaanxi Province's was diagnosed as hepatitis B in 2003, after develop into slight cirrhotic ascites, former decoction 30 clothes of taking Chinese medicine composition of the present invention are after three courses of treatment, liver function test is turned out cloudy, and not recurrence so far.
Zhang Fei, the man, 26 years old, people from Hangjin Rear Banner, the Inner Mongol detected in the time of 14 years old and suffers from hepatitis B, then develops into cirrhotic ascites, and it is come because of respect for the fame, and takes Chinese medicine composition of the present invention transference cure after 70 days, and liver function test is normal fully.
Through more than 30 years clinical treatments, found that Chinese medicine composition of the present invention to various hepatitis, liver cirrhosis clothes water spills smart liver and cirrhotic ascites, hepatocarcinoma, the therapeutic effect of digestive tract cancer and complication thereof is definite.
Embodiment 1
Take by weighing Radix Codonopsis 7.8% by mass percentage, the Radix Paeoniae Alba 7.8%, Fructus Schisandrae Chinensis 7.8%, Fructus Lycii 7.8%, Radix Rehmanniae Preparata 4.2%, Fructus Anisi Stellati 4.2%, Radix Notoginseng 4.2%, Radix Angelicae Pubescentis 4.2%, Poria 4.2%, Pericarpium Citri Reticulatae 2.6%, Fructus Crataegi 2.6%, the Rhizoma Atractylodis Macrocephalae 2.6%, Lignum Aquilariae Resinatum 4.6%, the Rhizoma Anemarrhenae 4.6%, Radix Adenophorae (Radix Glehniae) 2.8%, Radix Dipsaci 2.8%, Rhizoma Chuanxiong 2.8%, Radix Achyranthis Bidentatae 2.8%, Radix Gentianae Macrophyllae 2.8%, Semen Ziziphi Spinosae 2.8%, MUZHUA 2.8%, Radix Clematidis 2.8%, Radix Glycyrrhizae 2.8%, Radix Peucedani 2.8%, Cortex Cinnamomi 2.8%, above components contents summation is 100%; The above-mentioned all medicines that take by weighing evenly are in harmonious proportion, and grind into fine powder promptly.
Embodiment 2
Take by weighing Radix Codonopsis 9.8% by mass percentage, the Radix Paeoniae Alba 9.8%, Fructus Schisandrae Chinensis 9.8%, Fructus Lycii 9.8%, Radix Rehmanniae Preparata 6.6%, Fructus Anisi Stellati 6.6%, Radix Notoginseng 6.6%, Radix Angelicae Pubescentis 6.6%, Poria 6.6%, Pericarpium Citri Reticulatae 4.6%, Fructus Crataegi 4.6%, the Rhizoma Atractylodis Macrocephalae 4.6%, Lignum Aquilariae Resinatum 2.6%, the Rhizoma Anemarrhenae 2.6%, Radix Adenophorae (Radix Glehniae) 0.8%, Radix Dipsaci 0.8%, Rhizoma Chuanxiong 0.8%, Radix Achyranthis Bidentatae 0.8%, Radix Gentianae Macrophyllae 0.8%, Semen Ziziphi Spinosae 0.8%, MUZHUA 0.8%, Radix Clematidis 0.8%, Radix Glycyrrhizae 0.8%, Radix Peucedani 0.8%, Cortex Cinnamomi 0.8%, above components contents summation is 100%; The above-mentioned all medicines that take by weighing evenly are in harmonious proportion, and grind into fine powder promptly.
Embodiment 3
Take by weighing Radix Codonopsis 8.8% by mass percentage, the Radix Paeoniae Alba 8.8%, Fructus Schisandrae Chinensis 8.8%, Fructus Lycii 8.8%, Radix Rehmanniae Preparata 5.4%, Fructus Anisi Stellati 5.4%, Radix Notoginseng 5.4%, Radix Angelicae Pubescentis 5.4%, Poria 5.4%, Pericarpium Citri Reticulatae 3.6%, Fructus Crataegi 3.6%, the Rhizoma Atractylodis Macrocephalae 3.6%, Lignum Aquilariae Resinatum 3.6%, the Rhizoma Anemarrhenae 3.6%, Radix Adenophorae (Radix Glehniae) 1.8%, Radix Dipsaci 1.8%, Rhizoma Chuanxiong 1.8%, Radix Achyranthis Bidentatae 1.8%, Radix Gentianae Macrophyllae 1.8%, Semen Ziziphi Spinosae 1.8%, MUZHUA 1.8%, Radix Clematidis 1.8%, Radix Glycyrrhizae 1.8%, Radix Peucedani 1.8%, Cortex Cinnamomi 1.8%, above components contents summation is 100%; The above-mentioned all medicines that take by weighing evenly are in harmonious proportion, and grind into fine powder promptly.
Claims (2)
1. a Chinese medicine composition that is applicable to the treatment cirrhotic ascites is characterized in that, is made up of following raw material by mass percentage:
Radix Codonopsis 7.8%-9.8%, Radix Paeoniae Alba 7.8%-9.8%, Fructus Schisandrae Chinensis 7.8%-9.8%, Fructus Lycii 7.8%-9.8%, Radix Rehmanniae Preparata 4.2%-6.6%, Fructus Anisi Stellati 4.2%-6.6%, Radix Notoginseng 4.2%-6.6%, Radix Angelicae Pubescentis 4.2%-6.6%, Poria 4.2%-6.6%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, Fructus Chaenomelis 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%.
2. the preparation method of the described Chinese medicine composition of claim 1 is characterized in that, carries out according to following steps:
Step 1 takes by weighing Radix Codonopsis 7.8%-9.8% by mass percentage, Radix Paeoniae Alba 7.8%-9.8%, Fructus Schisandrae Chinensis 7.8%-9.8%, Fructus Lycii 7.8%-9.8%, Radix Rehmanniae Preparata 4.2%-6.6%, Fructus Anisi Stellati 4.2%-6.6%, Radix Notoginseng 4.2%-6.6%, Radix Angelicae Pubescentis 4.2%-6.6%, Poria 4.2%-6.6%, Pericarpium Citri Reticulatae 2.6%-4.6%, Fructus Crataegi 2.6%-4.6%, Rhizoma Atractylodis Macrocephalae 2.6%-4.6%, Lignum Aquilariae Resinatum 2.6%-4.6%, Rhizoma Anemarrhenae 2.6%-4.6%, Radix Adenophorae (Radix Glehniae) 0.8%-2.8%, Radix Dipsaci 0.8%-2.8%, Rhizoma Chuanxiong 0.8%-2.8%, Radix Achyranthis Bidentatae 0.8%-2.8%, Radix Gentianae Macrophyllae 0.8%-2.8%, Semen Ziziphi Spinosae 0.8%-2.8%, Fructus Chaenomelis 0.8%-2.8%, Radix Clematidis 0.8%-2.8%, Radix Glycyrrhizae 0.8%-2.8%, Radix Peucedani 0.8%-2.8%, Cortex Cinnamomi 0.8%-2.8%, above components contents summation is 100%;
Step 2, with all medicines that step 1 takes by weighing, even respectively mediation and grind into fine powder are promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009103125597A CN101816745B (en) | 2009-12-30 | 2009-12-30 | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009103125597A CN101816745B (en) | 2009-12-30 | 2009-12-30 | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101816745A CN101816745A (en) | 2010-09-01 |
| CN101816745B true CN101816745B (en) | 2011-09-28 |
Family
ID=42652122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009103125597A Expired - Fee Related CN101816745B (en) | 2009-12-30 | 2009-12-30 | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101816745B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656277B (en) * | 2013-11-27 | 2015-08-19 | 潍坊市现代风湿病研究院 | The medicine for the treatment of hepatic ascites |
| CN104587415A (en) * | 2015-02-17 | 2015-05-06 | 聂玮 | Heat clearing and diuresis promoting preparation for patients with cirrhosis and preparation method |
| CN104857373A (en) * | 2015-06-12 | 2015-08-26 | 汤华淑 | Traditional Chinese medicine composition for treating ascites due to cirrhosis |
-
2009
- 2009-12-30 CN CN2009103125597A patent/CN101816745B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101816745A (en) | 2010-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103041312B (en) | Traditional Chinese medicine composition with antineoplastic effect and preparation method and application thereof | |
| CN106267120A (en) | A kind of Chinese medicine for treating rhinitis preparation and preparation method thereof | |
| CN102526498B (en) | Chinese medicine for eliminating toxic and side effects after nasopharyngeal carcinoma radiotherapy and preparation method and administration way thereof | |
| CN102114099B (en) | Traditional Chinese medicine preparation for inhibiting liver cancer and preparation method thereof | |
| CN103386022A (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN101816745B (en) | Chinese medicine composite applicable to treating ascitesduetocirrhosis and preparation method thereof | |
| CN102198228A (en) | Chinese medicinal preparation for treating hypertension | |
| CN105213974A (en) | One treats lymphadenomatous Chinese medicine composition and application thereof | |
| CN103330837B (en) | Traditional Chinese medicine composition for curing osteoporosis of menopausal women | |
| CN103285343A (en) | Medicine for treating liver cancer and preparation method thereof | |
| CN103961506A (en) | Traditional Chinese medicine composition as traditional Chinese medicine regulatory human body cellular immunity agonist | |
| CN102488804B (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN105395842A (en) | Traditional Chinese medicine composition for treating diabetes and oral preparation and preparation method thereof | |
| CN101375962B (en) | Formulation for activating blood and freeing collateral vessels and preparation method thereof | |
| CN104825817A (en) | Traditional Chinese medicine preparation with antitumor effect | |
| CN101897908B (en) | Traditional Chinese medicine composition for treating cirrhosis ascites and liver cancer and preparation method thereof | |
| CN100384465C (en) | Chinese medicine for treating cancer and tumour and its preparation method | |
| CN104587056B (en) | A kind of Chinese medicine preparation and preparation method thereof for treating varicocele | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN102961704A (en) | Pharmaceutical composition for treating liver caner and method for preparing dispersible tablets thereof | |
| CN114452369B (en) | Traditional Chinese medicine composition for treating breast cancer | |
| CN100571739C (en) | Herbal mixture of treatment cardiovascular disease and preparation method thereof | |
| CN105770760A (en) | Preparation for treating gastric ulcer and preparation method thereof | |
| CN105663551A (en) | Traditional Chinese medicine preparation for patient suffering from pancreatic cancer to take after operation as well as preparation method | |
| CN105125949A (en) | Chinese drug preparation for treating syndromes after cholecystotomy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20151230 |
|
| EXPY | Termination of patent right or utility model |